Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No volume.... under 11,000 shares.....when??? when??? eom

IF.....the accompanying licenses reflect the "true" value of the '336 thats been promoted for all these years. I think dismissal of the 2nd request will boost short term interest but, it won't hold if the insuing licenses don't show substantial gains. That's less of my opinion and based more on the assertions made by TPL for all these years.

Share
New Message
Please login to post a reply